Professor Stephen Twigg
|
Professor
C39 - Royal Prince Alfred Hospital |
|
Current national competitive grants*
2012
Targeting proteases for a novel therapy for type 2 diabetes and liver complications.
Gorrell M, Twigg S, McLennan S, McCaughan G, Chowdhury S
Diabetes Australia Research Trust Research Grants ($59,814 over 1 year)
Incretins as Therapy in Diabetic Cardiomyopathy
Wang X, Twigg S
Diabetes Australia Research Trust Research Grants ($39,770 over 1 year)
Role of Inflammation in Diabetic Cardiomyopathy
Twigg S, King N, McLennan S
NHMRC Project Grants ($476,325 over 3 years)
2011
Preventing Adverse Effects of Matrix Metalloproteinases in Diabetic Wound Healing
McLennan S, Twigg S, Min D, Yue D
National Health and Medical Research Council Project Grant ($374,400 over 3 years)
2010
Unlocking genetic factors predicting type 2 diabetes complications for clinical practice: The Field Study
Keech A, Best J, Jenkins A, Sullivan D, Twigg S
NHMRC Project Grant ($2,428,501 over 2 years)
Diabetes exacerbates non-alcoholic steato-hepatitis (NASH)
Twigg S, McLennan S, Gorrell M
NHMRC Project Grant ($545,500 over 3 years)
Key role of connective tissue growth factor (CTGF) in familial cardiomyopathy and heart failure
Semsarian C, Twigg S, Tsoutsman T
NHMRC Project Grant ($381,125 over 3 years)
* Grants administered through the University of Sydney
PhD and Masters' project opportunities
Regulating prosclerosing growth factors by incretin therapy in diabetic cardiomyopathy